Other Events ·
ImmuCell reports $8.0M in Q3 product sales, a 46% increase year-over-year
ICCCImmucell Corp
ImmuCell Corporation announced preliminary, unaudited sales results for the third quarter ended September 30, 2026. Total product sales reached $8.0 million, representing a 46.0% increase compared to the same period in 2025. Domestic sales accounted for $6.9 million, up 29.2%. For the first nine months of 2026, total sales were $25.6 million, a 27.8% increase year-over-year. Management attributed the growth to sales team expansion and improved manufacturing reliability. The company stated it will discontinue early sales reporting in favor of standard quarterly financial metrics. ImmuCell Corporation is an animal-health biologics company that develops, manufactures and commercializes products for calf health solutions.